Paper36924454
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis.
Masi G and 9 others. Ann Clin Transl Neurol, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis. Papers, record 36924454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924454
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immune Checkpoint Inhibitors | Major topic |
| Myasthenia Gravis | Major topic |
| Humans | |
| Receptors, Cholinergic | |
| Autoantibodies | |
| Complement Activation |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U2C TR002818 | NCATS NIH HHS | United States | U2CTR002818 | PubMed and NIH | NIH RePORTER |
| R21 AI164590 | NIAID NIH HHS | United States | R21AI164590 | PubMed and NIH | NIH RePORTER |
| UL1 TR001863 | NCATS NIH HHS | United States | UL1TR001863 | PubMed | NIH RePORTER |
| R56 AI114780 | NIAID NIH HHS | United States | R01AI114780 | PubMed and NIH | NIH RePORTER |
| R01 AI114780 | NIAID NIH HHS | United States | R01AI114780 | PubMed and NIH | NIH RePORTER |
| U54 NS115054 | NINDS NIH HHS | United States | U54NS115054 | PubMed and NIH | NIH RePORTER |
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35366559 | The clinical need for clustered AChR cell-based assay testing of seronegative MG. | J Neuroimmunol | 2022 | https://conductscience.org/library/papers/35366559 | PubMed |
| 2 | 9232426 | Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. | Immunol Lett | 1997 | https://conductscience.org/library/papers/9232426 | PubMed |
| 3 | 31753014 | Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31753014 | PubMed |
| 4 | 31217355 | Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. | JCI Insight | 2019 | https://conductscience.org/library/papers/31217355 | PubMed |
| 5 | 36074148 | Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/36074148 | PubMed |
| 6 | 21814823 | Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. | J Neurol | 2012 | https://conductscience.org/library/papers/21814823 | PubMed |
| 7 | 34546336 | Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures. | J Exp Med | 2021 | https://conductscience.org/library/papers/34546336 | PubMed |
| 8 | 31562797 | Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31562797 | PubMed |
| 9 | 30185415 | Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/30185415 | PubMed |
| 10 | 34281989 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34281989 | PubMed |
| 11 | 35473886 | Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2022 | https://conductscience.org/library/papers/35473886 | PubMed |
| 12 | 35065039 | Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35065039 | PubMed |
| 13 | 19890000 | Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity. | J Neurosci | 2009 | https://conductscience.org/library/papers/19890000 | PubMed |
| 14 | 33305263 | Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. | Brain Commun | 2020 | https://conductscience.org/library/papers/33305263 | PubMed |
| 15 | 35065040 | Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35065040 | PubMed |
| 16 | 33653902 | Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review. | Neurology | 2021 | https://conductscience.org/library/papers/33653902 | PubMed |
| 17 | 32086972 | Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. | Ann Neurol | 2020 | https://conductscience.org/library/papers/32086972 | PubMed |
| 18 | 29931587 | Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. | Curr Treat Options Oncol | 2018 | https://conductscience.org/library/papers/29931587 | PubMed |
| 19 | 29320654 | Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29320654 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42558562 | Editorial: Toward predictive and mechanistic approaches for precision neuroimmunotoxicology. | Front Immunol | 2026 | https://conductscience.org/library/papers/42558562 | PubMed |
| 41940097 | Case Report and literature review: immune checkpoint inhibitor-associated myasthenia gravis and myocarditis. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41940097 | PubMed |
| 41835655 | Myasthenia-Like Presentations Following PD-1 Inhibitors: CD8+ Myositis, Myasthenia, or Both? | Cureus | 2026 | https://conductscience.org/library/papers/41835655 | PubMed |
| 41562147 | Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/41562147 | PubMed |
| 41111929 | Neuromuscular complications associated with cancer immunotherapy. | J Natl Cancer Cent | 2025 | https://conductscience.org/library/papers/41111929 | PubMed |
| 40506552 | Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events. | J Neurol | 2025 | https://conductscience.org/library/papers/40506552 | PubMed |
| 40455120 | Immune checkpoint inhibitor-related myasthenia gravis, myocarditis and myositis: further insights. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/40455120 | PubMed |
| 40246383 | Immune Checkpoint Inhibitor-Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes. | JACC CardioOncol | 2025 | https://conductscience.org/library/papers/40246383 | PubMed |
| 40181971 | Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota. | Front Immunol | 2025 | https://conductscience.org/library/papers/40181971 | PubMed |
| 39896961 | Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study. | Lancet Reg Health Eur | 2025 | https://conductscience.org/library/papers/39896961 | PubMed |
| 39745587 | Eculizumab as rescue therapy for relapse of myasthenia gravis after immune-checkpoint inhibitors: a case report. | Neurol Sci | 2025 | https://conductscience.org/library/papers/39745587 | PubMed |
| 39514829 | Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy. | Neurology | 2024 | https://conductscience.org/library/papers/39514829 | PubMed |
| 39122934 | Peripheral nervous system immune-related adverse events due to checkpoint inhibition. | Nat Rev Neurol | 2024 | https://conductscience.org/library/papers/39122934 | PubMed |
| 38954314 | Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors. | Curr Oncol Rep | 2024 | https://conductscience.org/library/papers/38954314 | PubMed |
| 37342323 | Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases. | Front Immunol | 2023 | https://conductscience.org/library/papers/37342323 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| LRP4 | 4038 | PubTator's text mining | https://conductscience.org/library/genes/4038 | NCBI Gene |
| MUSK | 4593 | PubTator's text mining | https://conductscience.org/library/genes/4593 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36924454
GET https://conductscience.org/api/papers/v1/36924454/authors